In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

New treatments, advanced medical devices, and innovations in everything from human health to animal health are driving growth in the pharmaceutical and biotechnology industries. The biotech and pharma ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

I examine the applicability of relative R&D spending as a potential leading indicator of shareholder returns. In addition, the correlation of R&D spending with stock volatility and sales growth is ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

From generics dominance to innovation leadership, India’s pharmaceutical sector is scaling rapidly through advanced ...